Manoochehr Makvandi

Prof. Manoochehr Makvandi


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2020 in IEEE Sensors Journal
Verified
Journal Article
Closed access
MFMona Fani
Mona Fani
MRMajid Rezayi
Majid Rezayi
ZMZahra Meshkat
Zahra Meshkat
SRSeyed Abdolrahim Rezaee
Seyed Abdolrahim Rezaee
MMManoochehr Makvandi
Manoochehr Makvandi
KAKambiz Ahmadi Angali
Kambiz Ahmadi Angali
An electrochemical DNA biosensor for the Human T-Lymphotropic Virus-1 (HTLV-1) detection was developed using differential pulse voltammetry (DPV). For this purpose, single-strand DNA (ssDNA) probe was immobilized on the screen-printed carbon electrode (SPCE) modified with nanocomposite of reduced graphene oxide, polypyrrole, and gold nanoparticles (rGO-PPy-AuNPs). Then, the hybridization with the target DNA was studied by measuring the electrochemical oxidation response of the anthraquinone-2-sulfonic acid sodium salt monohydrate (AQMS). The calibration curve displayed a linear range between 10-15 and 10-7 mol/L, with a detection limit of 40 atto-molar towards HTLV-1 DNA concentrations. This DNA sensing platform was successfully applied to detect the DNA extracted from Peripheral Blood Mononuclear Cells (PBMC) sample. Also, the specificity of the proposed biosensor was investigated by a positive sample of HTLV-1, a positive sample of HSV-1 (non-complementary sample), a mix-sample (HTLV-1 and HSV-1) and negative sample. Moreover, the relative standard deviation (RSD) of repeatability and reproducibility tests was 2.8 % and 4.3 % respectively, that it is less than 20% and demonstrates the good reusability and stability of the proposed biosensor.

1 July 2020 in Heliyon
Verified
Journal Article
Open access
NKNastaran Khodadad
Nastaran Khodadad
SSSeyed Saeed Seyedian
Seyed Saeed Seyedian
AMAfagh Moattari
Afagh Moattari
SHSomayeh Biparva Haghighi
Somayeh Biparva Haghighi
RPRoya Pirmoradi
Roya Pirmoradi
MMManoochehr Makvandi
Manoochehr Makvandi
Chronic hepatitis B (CHB) virus infection is the most prevalent chronic liver disease and has become a serious threat to human health. In this study, we attempted to specify and predict several properties including physicochemical, mutation sites, B-cell epitopes, phosphorylation sites, N-link, O-link glycosylation sites, and protein structures of S protein isolated from Ahvaz. Initially, hepatitis B virus DNA (HBV DNA) was extracted from five sera samples of untreated chronic hepatitis B patients. The full-length HBV genomes were amplified and then cloned in pTZ57 R/T vector. The full sequences of HBV were registered in the GenBank with accessions numbers (MK355500), (MK355501) and (MK693107-9). PROTSCALE, Expasy's ProtParam, immuneepitope, ABCpred, BcePred, Bepipred, Algpred, VaxiJen, SCRATCH, DiANNA, plus a number of online analytical processing tools were used to analyse and predict the preS/S gene of genotype D sequences. The present study is the first analytical research on samples obtained from Ahvaz. We found major hydrophilic region (MHR) mutations at “a” determining region that included K122R, N131T, F134Y, P142L, and T126N mutations. Moreover, Ahvaz sequences revealed four sites (4, 112, 166, and 309) in the preS/S gene for N-glycosylation that could possibly be a potential target for anti-HBV therapy. In the present study, mutations were identified at positions T113S and N131T within the MHR region of S protein; these mutations can potentially decrease the effect of hepatitis B vaccination in vaccine recipients.

1 October 2020 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
LDLila Karimi Dehcheshmeh
Lila Karimi Dehcheshmeh
MMManoochehr Makvandi
Manoochehr Makvandi
ATAli Timori
Ali Timori
JC virus (JCV) , and BK virus (BKV) can remain latency in kidney and excrete via urine asymptomatically. JCV has been associated with colorectal and bladder cancers. BKV has been linked with lung, pancreas, liver, urogenital tract, head and neck cancers. Therefore, the frequency of JCV DNA and BKV DNA are essential to evaluate in urine samples of healthy individuals. Materials and Methods: Hundred sixty four urine samples were collected from healthy subjects [96 females and 68 males]. DNA was extracted and detection of JCV DNA and BKV DNA was carried out by PCR . The analysis of sequencing and construction of phylogenetic tree were performed for the samples positive for JCV DNA and BKV DNA. Results: Ten (6.09%) urine samples [5/96(5.2%) females and 5/68( 8.82) males] were tested positive for JCV DNA (P= 0.814). The results of sequencing and phylogenetic tree showed the isolated JCV DNA were cluster with 3A genotype. 21/164 (12.8%) samples were tested positive for BKV DNA [11/96(11.45%) females and males 10/68(14.7%)] ( P= 0.63). The results of sequencing and phylogenetic tree showed that the isolated BKV was cluster with genotype III. Conclusion: In the present study 6.09% and 12.8% of the healthy individuals showed positive for JCV DNA (genotype 3A) and BKV DNA(genotype III) respectively. With regard to life threating diseases by BKV and JCV in immunocomprsied patients , the screening BKV DNA and JCV DNA should be implemented for patients with cancer /autoimmune diseases /organ recipient/ multiple sclerosis (MS), prior to immunosuppression therapy or immunomodulatory agents treatment.

1 August 2019 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
PSPeyman Sepahvand
Peyman Sepahvand
MMManoochehr Makvandi
Manoochehr Makvandi
ASAlireza Samarbafzadeh
Alireza Samarbafzadeh
ATAbdulhasan Talaei-Zadeh
Abdulhasan Talaei-Zadeh
NRNastaran Ranjbari
Nastaran Ranjbari
KAKambiz Ahmadi Angali
Kambiz Ahmadi Angali
Breast cancer is the most common cause of death among women worldwide. Although there are many known riskfactors in breast cancer development, infectious diseases have appeared as one of the important key to contribute tocarcinogenesis formation. The effects of Human Cytomegalovirus (HCMV) on women with breast cancer has beenrecently studied and reported. To contribute to this research trend, this study was conducted to evaluate the associationbetween HCMV and the women with breast cancer. Objective: This experiment aimed to evaluate HCMV DNA in womenwith breast cancer in Ahvaz city, Iran. Materials and Methods: A total of 37 formalin fixed paraffin embedded tissues ofthe patients with ductal breast carcinoma and 35 paraffin embedded tissues of the patients with fibro adenoma as controlgroup were collected. The deparaffinization of all the samples were carried out and the DNA was extracted. Initially,the PCR test was carried out to detect beta –globulin DNA as an internal control. For those samples positive for beta–globulin DNA, Polymerase Chain reaction (PCR) was used to detect HCMV for the tests and control samples. Results:Among 37 ductal breast carcinoma, 20 (54.04%) cases were proved positive for HCMV DNA by PCR. While amongthe 35 control group (fibroadenoma), 10 (28.57%) cases were positive for HCMV DNA (P >0.028). The prevalences ofHCMV DNA among the age groups 30-39, 40-49 and >50 years were 7 (72.22%), 9 (69.23%), 4 (57.14%), respectively(P=0.066). A high frequency of HCMV DNA was detected in tumor grade III, 13/18 (58.33%) compared with tumorgrade II, 7/19 (36.84%) (p=0.044). A high frequency of 16/24 (66.66%) of HCMV DNA was found in invasive ductalbreast cancer compared with 4/13 (30.76%) HCMV DNA in situ (P<0.028). Conclusion: A high prevalence of 54.05%HCMV was found among the patients with ductal carcinoma. The percentages of the high prevalence of HCMV amongage group (40-49) years, tumors grades, and invasive stage were (69.23%), (58.33%), (66.66%), respectively. Furtherstudy of HCMV in the latency phase in patients with ductal carcinoma would be necessary to extend our knowledge.

24 February 2021 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
PDF file
SMShahab Mahmoudvand
Shahab Mahmoudvand
SSSomayeh Shokri
Somayeh Shokri
MMManoochehr Makvandi
Manoochehr Makvandi
RTReza Taherkhani
Reza Taherkhani
MRMohammad Rashno
Mohammad Rashno
KAKambiz Ahmadi Angali
Kambiz Ahmadi Angali

1 April 2019 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
ANAzadeh Haghi Navand
Azadeh Haghi Navand
ATAli Teimoori
Ali Teimoori
MMManoochehr Makvandi
Manoochehr Makvandi
NNNilofar Nisi
Nilofar Nisi
SSSeyed Saeid Seyedian
Seyed Saeid Seyedian
KPKeyvan Pourjabari
Keyvan Pourjabari
Colorectal cancer is the most repetitious malignancies with high mortality worldwide. JC virus (JCV) is ubiquitousPolyomavirus, with seroprevalence rates ranging from 70% to 90% in adult population. Recently the role of JCV havebeen reported in many malignant tumors worldwide. The association of JCV was reported in patients with colon andrectum cancers. Thus this study was conducted to evaluate the association of JCV DNA in patients with colon cancertype Adenocarcinoma. Material and Methods: A total of 120 formalin-fixed paraffin-embedded tissue blocks sampleswere collected including 20/40(50%) males, 20/40(50%) females patients with Colorectal Cancer(CRC), and 80 (50%males, 50% females) patients with benign tumor as a control. DNA was extracted for all the samples. Nested PCR wascarried out for detection of Vp1/T-Ag junction genome in JCV genome by Nested-PCR assay. Randomly, PCR productsof 6 samples were sequenced to analysis the partial JCV DNA. The phylogeny tree was constructed to determinehomology identity with other JCV. Results: 4/40(10%) samples of test group and 10/80 (12.5%) of control sampleswere positive for JCV DNA (P= 0.69). Out of 4 samples positive for JC DNA, 3(7.5%) were males and 1(2.4%) female(P=0.29). The frequency of JCV DNA in age group> 50 years was 4/32(10%), while in age group (0%) (p= 0.29). Conclusion: prevalence of JCV DNA was among 10% patients with CRC and 12.5% benign tumors(p=0.69). The distribution of JCV DNA was among 7.5% male and 2.5% female (p= 0.29). The frequency of JCVDNA was among 10% cases of age group >50 years and 0% of age group protein expression might explain the increased risk of colorectal cancer and requires further investigation.